0 results available. Select is focused ,type to refine list, press Down to open the menu,
The following section summarizes insights on 's Return on Common Equity:
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Return on Common Equity in the efficiency category include:
A ratio used to measure the return that a firm generates on the book value of common equity.
Return on Common Equity is defined as:
Return on Common Equity = Net Income To Common / Average Total Common Equity
Return on Common Equity for Tarsus Pharmaceuticals is calculated as follows:
Net Income [ -115.6 M ]
(/) Average Equity over Period [ 210.8 M ]
(=) Return on Common Equity [ −54.8% ]
The tables below summarizes the trend in Tarsus Pharmaceuticals’s return on common equity over the last five years:
| Fiscal Year | Net Income | Average Common Equity | Return on Common Equity |
|---|---|---|---|
| 2020-12-31 | -26.811 M | 82.99 M | −32.3% |
| 2021-12-31 | -13.827 M | 166.4 M | −8.3% |
| 2022-12-31 | -62.091 M | 179.8 M | −34.5% |
| 2023-12-31 | -135.9 M | 194.9 M | −69.7% |
| 2024-12-31 | -115.6 M | 210.8 M | −54.8% |
Return on equity represents the percentage return a company generates on the money shareholders have invested.
The Net Income used in the numerator is often adjusted for one-time and non-recurring items to present a clearer view of future earnings. Since income is earned over the course of a year, we average book value of Common Equity at the start and end of the year for the denominator.
In general, a higher return on equity suggests management is utilizing the capital invested by shareholders efficiently.
The chart above depicts the distribution of return on common equity for companies operating in the Healthcare sector in the Developed economic region. Over 2,100 companies were considered in this analysis, and 2,022 had meaningful values. The average return on common equity of companies in the sector is -89.4% with a standard deviation of 173.0%.
Tarsus Pharmaceuticals Inc's Return on Common Equity of -54.8% ranks in the 39.7% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,105 |
| Included Constituents | 2,022 |
| Min | -1,413.6% |
| Max | 50.2% |
| Median | -34.1% |
| Mean | -89.4% |
| Standard Deviation | 173.0% |
You can find companies with similar return on common equity using this stock screener.